GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Humanwell Healthcare (Group) Co Ltd (SHSE:600079) » Definitions » 9-Day RSI

Humanwell Healthcare (Group) Co (SHSE:600079) 9-Day RSI : 50.12 (As of Apr. 11, 2025)


View and export this data going back to 1997. Start your Free Trial

What is Humanwell Healthcare (Group) Co 9-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2025-04-11), Humanwell Healthcare (Group) Co's 9-Day RSI is 50.12.

The industry rank for Humanwell Healthcare (Group) Co's 9-Day RSI or its related term are showing as below:

SHSE:600079's 9-Day RSI is ranked worse than
77.34% of 1077 companies
in the Drug Manufacturers industry
Industry Median: 42.09 vs SHSE:600079: 50.12

Competitive Comparison of Humanwell Healthcare (Group) Co's 9-Day RSI

For the Drug Manufacturers - Specialty & Generic subindustry, Humanwell Healthcare (Group) Co's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Humanwell Healthcare (Group) Co's 9-Day RSI Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Humanwell Healthcare (Group) Co's 9-Day RSI distribution charts can be found below:

* The bar in red indicates where Humanwell Healthcare (Group) Co's 9-Day RSI falls into.


;
;

Humanwell Healthcare (Group) Co  (SHSE:600079) 9-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Humanwell Healthcare (Group) Co  (SHSE:600079) 9-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.


Humanwell Healthcare (Group) Co 9-Day RSI Related Terms

Thank you for viewing the detailed overview of Humanwell Healthcare (Group) Co's 9-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Humanwell Healthcare (Group) Co Business Description

Traded in Other Exchanges
N/A
Address
No.666 Gaoxin Road, East Lake High-tech Development Zone, Hubei, Hubei Province, Wuhan, CHN, 430075
Humanwell Healthcare (Group) Co Ltd is a China-based integrated healthcare solution provider. Being a pharmaceutical company, it provides medicinal products including fertility-regulating drugs, Uygur medicine, traditional Chinese medicine, medical devices, over-the-counter medicines, anti-infection drugs, herbal medicines, and biological products. The organization has a business presence in China and other international countries.
Executives
Wang Xue Hai Director
Li Jie Director
Xu Hua Bin senior management
Du Wen Tao senior management
Wu Ya Jun senior management
Deng Xia Fei Directors, senior managers
Li Li E senior management
Yu Qun senior management
Zhang Hong Jie senior management
Yin Qiang senior management
Li Qian Lun senior management
Gai Song Mei Supervisors
Zhang Xiao Dong Director
Liu Yi senior management
Ai Lu Ming Director

Humanwell Healthcare (Group) Co Headlines

No Headlines